Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Raymond E. Meyn
MK-8776, a Novel Chk1 Kinase Inhibitor, Radiosensitizes P53-Defective Human Tumor Cells
Oncotarget
Oncology
Related publications
The Chk1 Inhibitor MK-8776 Increases the Radiosensitivity of Human Triple-Negative Breast Cancer by Inhibiting Autophagy
Acta Pharmacologica Sinica
Medicine
Pharmacology
The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair
Molecular Cancer Therapeutics
Cancer Research
Oncology
Small-Molecule Inhibition of Wee1 Kinase by MK-1775 Selectively Sensitizes P53-Deficient Tumor Cells to DNA-damaging Agents
Molecular Cancer Therapeutics
Cancer Research
Oncology
Erratum: Corrigendum: A Ruthenium Polypyridyl Intercalator Stalls DNA Replication Forks, Radiosensitizes Human Cancer Cells and Is Enhanced by Chk1 Inhibition
Scientific Reports
Multidisciplinary
CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Designed Inhibitor of P53 Aggregation Rescues P53 Tumor Suppression in Ovarian Carcinomas
Cancer Cell
Cancer Research
Oncology
Cell Biology
Novel CHK1 Inhibitor MU380 Exhibits Significant Single-Agent Activity in TP53-mutated Chronic Lymphocytic Leukemia Cells
Haematologica
Hematology
Chk1 Inhibition Activates P53 Through P38 MAPK in Tetraploid Cancer Cells
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
MLN8054, an Inhibitor of Aurora a Kinase, Induces Senescence in Human Tumor Cells Both in Vitro and in Vivo
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
